[go: up one dir, main page]

ES2087178T3 - Disulfato de ws7622a, procedimiento para su preparacion y su uso. - Google Patents

Disulfato de ws7622a, procedimiento para su preparacion y su uso.

Info

Publication number
ES2087178T3
ES2087178T3 ES91110243T ES91110243T ES2087178T3 ES 2087178 T3 ES2087178 T3 ES 2087178T3 ES 91110243 T ES91110243 T ES 91110243T ES 91110243 T ES91110243 T ES 91110243T ES 2087178 T3 ES2087178 T3 ES 2087178T3
Authority
ES
Spain
Prior art keywords
procedure
preparation
ws7622a disulfate
ws7622a
disulfate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91110243T
Other languages
English (en)
Inventor
Shigehiro Takase
Hiroshi Hatanaka
Masami Ezaki
Eisaku Tsujii
Masanori Okamoto
Nobuharu Shigematsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2087178T3 publication Critical patent/ES2087178T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/04—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Transplantation (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)

Abstract

MONOERSE CULTIVANDO ESTRECTOMICINAS RESISTOMICIFICUS NO.7622 (FERM BP-2306), PROCESOS PARA PREPARAR ESTOS SULFATOS Y COMPOSICIONES FARMACEUTICAS QUE CONTIENEN ESTOS COMPUESTOS O SUS SALES FARMACEUTICAMENTE ACEPTABLES COMO UN INGREDIENTE ACTIVO.
ES91110243T 1990-06-29 1991-06-21 Disulfato de ws7622a, procedimiento para su preparacion y su uso. Expired - Lifetime ES2087178T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909014546A GB9014546D0 (en) 1990-06-29 1990-06-29 Ws7622a mono-or di-sulfate,process for preparation thereof and use thereof

Publications (1)

Publication Number Publication Date
ES2087178T3 true ES2087178T3 (es) 1996-07-16

Family

ID=10678456

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91110243T Expired - Lifetime ES2087178T3 (es) 1990-06-29 1991-06-21 Disulfato de ws7622a, procedimiento para su preparacion y su uso.

Country Status (22)

Country Link
US (2) US5292510A (es)
EP (1) EP0465895B1 (es)
JP (1) JP2663763B2 (es)
KR (1) KR100198693B1 (es)
CN (1) CN1073115C (es)
AT (1) ATE138074T1 (es)
AU (1) AU640241B2 (es)
CA (1) CA2045761C (es)
DE (1) DE69119488T2 (es)
DK (1) DK0465895T3 (es)
ES (1) ES2087178T3 (es)
FI (1) FI106554B (es)
GB (1) GB9014546D0 (es)
GR (1) GR3020184T3 (es)
HU (1) HU213398B (es)
IE (1) IE75702B1 (es)
IL (1) IL98394A (es)
NO (1) NO301643B1 (es)
PH (1) PH31239A (es)
PT (1) PT98134B (es)
RU (1) RU2087482C1 (es)
ZA (1) ZA914349B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69223455T2 (de) * 1991-06-18 1998-04-02 Fujisawa Pharmaceutical Co WS7622A enthaltende prophylaktische/therapeutische Zusammensetzung zur Vorbeugung und Behandlung von verstreuter, intravaskulärer Koagulation, chronischer, infektiöser Atemwegskrankheiten oder chronischer Bronchitis
US5384119A (en) * 1993-08-12 1995-01-24 Merrell Dow Pharmaceuticals Inc. Method of preventing neutrophil mediated connective tissue damage
JP2002161051A (ja) * 1996-12-24 2002-06-04 Fujisawa Pharmaceut Co Ltd 脳虚血性疾患等の治療剤
WO1999043352A1 (en) * 1998-02-24 1999-09-02 Fujisawa Pharmaceutical Co., Ltd. Preventives/remedies for skin aging
CN109406709B (zh) * 2018-12-27 2020-11-10 福建省中医药研究院(福建省青草药开发服务中心） 一种太子参药材中氨基酸类成分的薄层鉴别方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH27266A (en) * 1989-03-14 1993-05-04 Fujisawa Pharmaceutical Co WS7622, A,B,C and D substances and pharmaceutical composition containing same

Also Published As

Publication number Publication date
PT98134B (pt) 1998-12-31
PH31239A (en) 1998-06-18
PT98134A (pt) 1992-06-30
HUT58351A (en) 1992-02-28
US5364624A (en) 1994-11-15
GR3020184T3 (en) 1996-09-30
JPH04279600A (ja) 1992-10-05
FI106554B (fi) 2001-02-28
DE69119488T2 (de) 1996-10-02
IE912047A1 (en) 1992-01-01
KR920000920A (ko) 1992-01-29
NO912561L (no) 1991-12-30
FI912914A0 (fi) 1991-06-17
IE75702B1 (en) 1997-09-10
GB9014546D0 (en) 1990-08-22
ATE138074T1 (de) 1996-06-15
RU2087482C1 (ru) 1997-08-20
IL98394A0 (en) 1992-07-15
CN1057655A (zh) 1992-01-08
ZA914349B (en) 1992-03-25
EP0465895B1 (en) 1996-05-15
HU912198D0 (en) 1991-12-30
NO301643B1 (no) 1997-11-24
CN1073115C (zh) 2001-10-17
NO912561D0 (no) 1991-06-28
JP2663763B2 (ja) 1997-10-15
FI912914L (fi) 1991-12-30
KR100198693B1 (ko) 1999-06-15
CA2045761C (en) 1999-09-21
AU7939491A (en) 1992-01-09
HU213398B (en) 1997-06-30
IL98394A (en) 1995-03-30
EP0465895A1 (en) 1992-01-15
US5292510A (en) 1994-03-08
CA2045761A1 (en) 1991-12-30
DK0465895T3 (da) 1996-06-03
DE69119488D1 (de) 1996-06-20
AU640241B2 (en) 1993-08-19

Similar Documents

Publication Publication Date Title
ES2090713T3 (es) Sales organicas de n,n'-diacetil-cistina.
PT97689A (pt) Processo para a preparacao de composicoes farmaceuticas incorporando como ingrediente activo isoxazol-4-carboxilamida e hidroxialquilideno-cianoacetamida
ECSP941104A (es) Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
AR005703A1 (es) Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen
ES2052603T3 (es) Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
ES2095432T3 (es) Derivados de 2,4-tiazolidin-diona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2075202T3 (es) Nuevas arilpiridazinas, su preparacion, su utilizacion, y medicamentos que las contienen.
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
ES2058411T3 (es) Sustancia fr 901228 y su preparacion.
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
FI20001231A7 (fi) 2-Deoksi-2,3-didehydro-N-asetyylineuramiinihapon johdannaisia ja niiden analogeja ja niiden käyttö antiviraalisina aineina
MX9204354A (es) Compuestos heterociclicos de 5 miembros, procedimiento para prepararlos y composiciones farmaceuticas que los contienen.
MX9200180A (es) DERIVADOS DE LA 5H-PIRROL (3,4-b) PIRAZINA OPTICAMENTE ACTIVOS, PROCEDIMIENTO PARA SU PREPARACION Y COMPOSICION FARMACEUTICA QUE LOS CONTIENE.
ES2144192T3 (es) Nuevos derivados de 1-fenil-2-dimetil-amino-metil-ciclohexan-1-ol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
MX9100990A (es) Compuesto monohidrato de furoato de mometasona,al procedimiento para su preparacion y a las composiciones farmaceuticas
ES2083668T3 (es) Combinaciones antiviricas que contienen analogos de nucleosidos.
MX9207494A (es) 4(5)-amino-1,8-naftiridinas substituidas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
ES2102475T3 (es) Nuevas alquil-amidas heterociclicas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
AR003427A1 (es) Péptidos relacionados con dolastatina, procedimiento para prepararlos, composiciones farmacéuticas que los contienen y el uso de los mismos para la preparación de dichas composiciones farmacéuticas.
MX9207449A (es) Inhibidores de la enzima proteolitica derivada de sacarina.
AR012294A1 (es) Derivados de sulfonamida, un procedimiento para su preparacion, composiciones farmaceuticas que los contienen, uso de dichos derivados para lapreparacion de un medicamento.
ES2111556T3 (es) Nuevas aminas alquil-heterociclicas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
MX9704037A (es) 1,1-dioxidos de 1,2,5-tiadiazolidin-3-ona 2-substituida y composiciones y metodo de uso de los mismos.
ECSP930933A (es) Composicion farmaceutica y procedimiento para prepararla
ES2062137T3 (es) Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 0465895

Country of ref document: ES